2024 annual financial data
ImmuCell 2024 Operating margin
ImmuCell 2024 operating margin with verified reported values.
Direct answer
Operating margin was -6.19%.
Operating income was -1,640,159 USD and net income was -2,156,629 USD.
Operating cash flow was 357,903 USD.
Get free ImmuCell email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 26,493,169 USD
- Operating income
- -1,640,159 USD
- Net income
- -2,156,629 USD
- Operating cash flow
- 357,903 USD